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Further Insights into the C1 Activation Mechanism
mediated activation of C1s. Once activated, C1s will
initiate a series of highly specific proteolytic reactions,
resulting in diverse biological responses designed to
provide a first line of defense against infection. The
classical pathway of complement is also involved in
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1LCCP and immune tolerance, due to its ability to recognize and
induce clearance of apoptotic cells [7], and plays a major2 LEM
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of the classical complement pathway lies in the abilityCEA-CNRS
41 rue Jules Horowitz of C1 to recognize antigenic structures from self, thereby
triggering inappropriate effector reactions involved in38027 Grenoble cedex 1
France various pathologies, including Alzheimer’s [9, 10] and
prion diseases [11, 12]. These deleterious side effects3 BASF and
4 ABBOTT GmbH of the classical complement pathway underline the need
to develop strategies to control its activation, and, be-67065 Ludwigshafen
Germany cause of their high substrate specificity, the proteases
of the C1 complex appear as suitable targets for this
purpose.
Low-resolution models of the C1 complex have beenSummary
proposed [4, 13, 14], featuring folding of the C1s-C1r-C1r-
C1s tetramer into a compact, “8”-shaped conformationC1r is the serine protease (SP) that mediates autoacti-
that, at the macroscopic level, account for the two-stepvation of C1, the complex that triggers the classical
activation process of C1. However, the mechanisms bycomplement pathway. We have determined the crystal
which C1r activates itself, and subsequently cleavesstructure of two fragments from the human C1r cata-
C1s, remain to be elucidated at the atomic level. Tolytic domain, each encompassing the second comple-
decipher the structure and activation mechanism of hu-ment control protein (CCP2) module and the SP do-
man C1, we have undertaken the dissection of this multi-main. The wild-type species has an active structure,
molecular complex [5]. Thus, the crystal structure of awhereas the S637A mutant is a zymogen. The struc-
catalytic CCP2-SP fragment from C1s, comprising thetures reveal a restricted hinge flexibility of the CCP2-
second complement control protein (CCP2) module [15]SP interface, and both are characterized by the unique
and the serine protease (SP) domain, was the first to be-helical conformation of loop E. The zymogen activa-
solved, providing insights into the substrate specificitytion domain exhibits high mobility, and the active
of C1s and its function in the context of the C1 complexstructure shows a restricted access to most substrate
[16]. More recently, we have determined the three-binding subsites. Further implications relevant to the
dimensional structure of the catalytic domain of C1r [17].C1r self-activation process are derived from protein-
The recombinant fragment comprised the CCP1 andprotein interactions in the crystals.
CCP2 modules and the SP domain, and was stabilized
in the zymogen form by means of an Arg to Gln mutation
Introduction at the Arg446Ile447 site normally cleaved upon activa-
tion. The structure shows a homodimeric assembly sta-
Complement is a major system of innate immunity in bilized by interactions between the CCP1 module of one
mammals and other vertebrates due to its ability to limit monomer and the SP domain of its counterpart, implying
infection in the early phase after exposure to pathogens, that C1r activation in C1 requires dissociation of the
and its capability to instruct and stimulate the subse- dimer through disruption of the CCP1-SP interfaces.
quent acquired immune response [1, 2]. One of the three In this report, we describe the X-ray structures of
routes of complement activation, the classical pathway, two monomeric CCP2-SP fragments from the catalytic
is triggered by C1, a 790,000 Da multimolecular complex region of human C1r. One was expressed with the wild-
resulting from the association of a recognition protein, type sequence and exhibits the active conformation,
C1q, with two modular serine proteases, C1r and C1s and the other was stabilized in the zymogen state by
[3–5]. C1q is a hexameric molecule with the overall means of a mutation of the active site serine (Ser637Ala)
shape of a bunch of tulips, each comprising a collagen- [18]. These two additional structures show that the
like helix prolonged by C-terminal heterotrimeric globu- CCP2-SP interface of C1r has restricted flexibility and
lar domains of the gC1q type [6]. Binding of C1q through unveil the details of the structural changes that take
its globular domains to pathogens or to other target place upon activation of the SP domain. The active C1r
structures triggers activation of the Ca2-dependent structure also explains the highly restricted substrate
C1s-C1r-C1r-C1s catalytic subunit, a two-step process specificity of this protease, and opens the way to the
involving C1r autolytic activation and subsequent C1r-
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CCP2 module. Thus, in contrast to our initial hypothesisTable 1. Refinement Statistics for the Active (WT) and
based on the remarkable similarity between the CCP2-Proenzyme (S637A) Structures
SP assemblies in the C1r R446Q and C1s structures [16,
Active Proenzyme
17], it is clear from the above data that the CCP2-SPResolution range (A˚) 50–2.8 50–3.2
interface is not completely rigid in C1r. A close inspec-Number of unique reflections 10,191 11,104
tion of the structure reveals that the flexibility originatesRwork (%) 20.97 21.65
Rfree (%) 25.45 27.86 from a hinge near Val433, in the 15-residue long activa-
Number of protein residues 313 306 tion peptide that connects the CCP2 module to the SP
Average B factor (A˚2) 48 34.8 domain. As detailed in Figure 1C, the displacements of
Number of water molecules 98 139
the CCP2 module observed in Figure 1A result fromRmsd bond length (A˚) 0.007 0.007
slight differences in the orientation of the polypeptideRmsd bond angle () 1.4 1.4
chain at this level, further amplified through strand B6
along the chain toward the N-terminal end of the CCP2
module. However, this hinge has restricted flexibility,
rational design of specific inhibitors. Finally, examina- mainly due to structural constraints arising from the
tion of the SP-SP interaction in the zymogen and active location of Val433 in between Pro432 and Cys434, the
fragment crystals sheds light on the way these mole- latter being connected by a disulfide bond to Cys560
cules may interact upon activation. of the SP domain. Analysis of the CCP2-SP interface
reveals that, compared to R446Q, the S637A structure
Results and Discussion lacks several van der Waals contacts in the vicinity of the
hinge region, and that several H bonds exhibit increased
We have determined the three-dimensional structure of distances. Altogether, these modifications substanti-
two fragments from the catalytic domain of human C1r. ally destabilize the CCP2-SP interface in the S637A
Both encompass the CCP2 module and the C-terminal structure.
SP domain (residues 358–688) and were expressed in
a baculovirus/insect cell system. The wild-type species
(WT) is recovered as a cleaved, active protease, whereas Structure of the Active SP Domain
the S637A mutant is stabilized in the uncleaved, proen- As expected, the active form of the C1r SP domain
zyme state by means of substitution of Ala for the cata- as seen in the WT fragment has a much more stable
lytic Ser637(c195) residue (C1r numbering, followed by conformation than its zymogen counterparts. Only the
chymotrypsinogen numbering in brackets, will be used short 493(c61D)–497(c61H) segment, at the tip of loop
throughout for residues of the SP domain). The molecu- B, (the loop nomenclature of Perona and Craik [19] is
lar replacement search model composed of the corre- used throughout the article; see Table 2) does not have
sponding CCP2-SP segment of the previously deter- matching electron density (Figure 2). Loops 3 and D,
mined structure of the R446Q C1r mutant [17] yielded both highly flexible in the zymogen structures, are very
a straightforward solution in both cases. The WT and well defined in the active SP domain. Interestingly, loop
S637A structures were refined at 2.8 A˚ and 3.2 A˚ resolu- E (residues 510[c74]–517[c82]) exhibits the same un-
tion, respectively (see Experimental Procedures). The usual-helical conformation in both monomeric WT (see
final Rwork and Rfree factors are 0.209 and 0.254 for WT Figure 2) and S637A structures, as previously observed
and 0.216 and 0.279 for S637A, and the stereochemistry in the R446Q homodimer [17]. It is clear, therefore, that
of the models is of good quality (Table 1). the helical fold of this loop, which is heavily involved in
the CCP1-SP dimer interface, is not a consequence of
dimer formation, but is an intrinsic feature of the C1r SPOverall Structure: Limited Flexibility
of the CCP2-SP Interface domain.
Comparison of the active structure of the C1r SP do-The WT and S637A fragments exhibit overall structures
comparable to those originally observed in the R446Q main with those of C1s [16] and other chymotrypsin-like
SPs reveals a number of significant differences (Figuremutant [17], with the CCP2 module closely interacting
with the SP domain on the side opposite the catalytic 2; Table 2). Some of these are due to insertions or dele-
tions, as in surface loops A, B, D, 1, and 2, which havetriad, its long axis being roughly perpendicular to the
surface of the protease (Figure 1A). However, compared different lengths in C1s but otherwise exhibit similar
conformations (Figure 2). Loop A is shorter in C1r thanto the virtually identical CCP2-SP assemblies seen in
the two monomers of the homodimeric R446Q mutant in most of the other SPs except C1s, and shows an
unusual orientation, with a 2-residue increase in thestructure, the orientation of the CCP2 module with re-
spect to the SP domain is substantially different in the length of the preceding  strand. Loop B represents a
major insertion, with up to 8 extra residues as comparedmonomeric WT and S637A fragments. Thus, alignment
of the CCP2-SP assemblies on the SP domain structure to chymotrypsin, and only 1 fewer residue than the
largest loop observed in thrombin [20]. Interestingly, thisreveals displacement of the CCP2 module toward oppo-
site directions in the WT and S637A molecules (Figure loop is flexible, with 5 residues (493[c61D]–497[c61H])
having no matching electron density. Loop C contains1A). Conversely, superposition of the assemblies on the
CCP2 module structure (Figure 1B) shows extensive dis- a minor insertion compared to most other SPs, but is
nevertheless shorter than in thrombin and C1s (Figureplacement of the SP domains, with a distance of 8.9 A˚
between the Ser/Ala637(c195) catalytic residue C posi- 2), whereas loop D is consistently shorter than in other
SPs. A striking difference occurs in loop E (the Ca2tion in WT and S637A, corresponding to a rotation of
21.7of the SP domain with respect to the long axis of the binding loop in other SPs), where C1r is the only chymo-
Monomeric Structures of C1r Catalytic Domain
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Figure 1. Overall Structures of the C1r CCP2-SP Assemblies
The WT, S637A, and R446Q molecules are shown in green, red, and cyan, respectively. The structure shown for R446Q is that of molecule
B of the R446Q dimer [17].
(A) Superimposition of the S637A and WT structures (stereo view). Loops are labeled according to Perona and Craik [19]. a.s., active site.
(B) Superposition of the assemblies on the CCP2 module structures (partial view), illustrating the divergent orientations of the polypeptide
chain in the SP domains.
(C) Detailed view of the hinge region in the three structures. Residues Pro432, Val433, Cys434, and Cys560 are shown as balls and sticks.
Structure
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Table 2. Structural Comparison of the Active C1r SP Domain with Homologous X-Ray Structures
Overall structure
C1s  Thrombin Factor IXa Factor Xa Chymotrypsin
Global rms (A˚) 1.13 1.19 1.30 1.19 1.25
Number of homologous C 205 211 205 206 212
PDB ID code 1elv 1mkx 1pfx 1hcg 1ab9
Specific C1r surface segments significantly different (D  1.5 A˚) from the homologous segments of the above selected active serine
proteases
C1r Chy
Loop label [19] number number Other name
A 465–469 34–41 37 loop
B 487–502 59–66 60 loop, histidine loop
E 510–517 74–82 Ca2 binding loop
C 530–536 95–98 94 shunt, 99 loop
562–571 124–133
D 583–586 145–151 autolysis loop
3 605–615 170–175 methionine loop
1 625–629 185–187 186 loop
645–650 203–206
2 661–665 217–223 S1 entrance frame
685–686… 243–245… C-terminal
trypsin-like SP known to exhibit an -helical fold (Figure SP domain in complex with a specific peptide inhibitor.
However, several protease-inhibitor complex structures2). This loop is much longer in C1r than in C1s, but
slightly shorter than in other proteases. Loop 3 of C1r are available, providing information on the canonical
conformation of these sites in serine proteases [23]. Werepresents a major insertion, although it is shorter than
its C1s counterpart, which is partly disordered (Figure have used this information to locate the putative C1r
binding subsites and to analyze their environment and2). This C1r loop also exhibits an -helical structure, a
feature that is shared, to a lesser extent, by most of the their accessibility. As previously observed in C1s [16]
and in several blood coagulation proteases [21], it maySPs [21, 22]. Compared to other SPs, further significant
structural differences are observed in segments be concluded from this analysis that the access to the
C1r substrate binding subsites is highly restricted. The562(c124)–571(c133) and 645(c203)–650(c206), on the
same side of the SP domain (Figure 2). only exceptions are the S1 and S1 subsites (the nomen-
clature used is that of Schechter and Berger [24]). In
contrast to C1s, S1 is widely accessible (Figure 3), and,Substrate Specificity of C1r
Precise characterization of the substrate binding sub- due to the crystal packing, is occupied by Arg444(c13),
the P3 residue lying two positions upstream from thesites of C1r will require crystallographic analysis of its
Figure 2. Comparison of the Active Structures of the C1r and C1s SP Domains
The superimposed structures of C1r (red) and C1s (green) are shown in stereo view. Loops are labeled according to Perona and Craik [19].
Residues His485(c57) and Ser637(c195) of the catalytic triad, and Asp631(c189) are shown as balls and sticks and labeled a.s. The asterisk
indicates Ile447(c16). The positions of residues 444(c13) (the C terminus of the activation peptide), 570(c132), and 647(c203B) are also indicated.
Dots represent the single disordered segment 493(c61D)–496(c61H) of the C1r structure. In the case of C1s, only surface loops differing from
the common core are shown, for the sake of clarity.
Monomeric Structures of C1r Catalytic Domain
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Figure 3. Specific Features of the C1r Substrate Binding Subsites
(A) Surface view of the substrate binding subsites area. A model peptide (shown in blue), with the P3 to P2 residues from C1r, was superimposed
on the C1r structure. The location of the side chains of some of the residues restricting access to these subsites is indicated (chymotrypsinogen
residue numbering). The molecule is shown in the standard orientation [21].
(B) Sequences around the C1r-specific cleavage sites in human C1r, C1s, and C1 inhibitor. The numbering nomenclature of the residues on
either sides of the susceptible bond is that of Schechter and Berger [24].
Arg446-Ile447 cleavage site from a neighboring mole- On the opposite side of the active site, the S1 site
has a rather open structure defined essentially by resi-cule. The edge of the S1 pocket is formed in a typical
manner by small residues, including Gly660(c216), dues of the A loop (also known as the “37 loop”; see
Table 2), namely Phe463(c32), Thr464(c33), Ile466(c38),Gly662(c219), Gly668(c226), Ala632(c190), Ser658(c214),
the active site Ser637(c195), and the Cys633(c191)- His467(c39), Gly468(c40), Arg469(c41), Gly471(c43), and
Thr486(c58) (Figure 3). The neighboring S2 site, in con-Cys663(c220) disulfide bridge. A further canonical deter-
minant of the S1 site in trypsin-like SPs that is conserved trast, is obstructed by Arg469(c41), a feature shared by
the corresponding site of C1s [16]. The edge of the S2in C1r is Asp631(c189), at the bottom of the S1 pocket.
As previously observed in C1s [16], the bottom of this pocket is made up of residues Gly635(c193), Gly580(c142),
Phe463(c32), Phe579(c141), and Gln634(c192), the latterpocket is closed at the level of Tyr667(c225) and
Pro626(c185). Thus, despite the presence of Tyr at posi- lying in between S2 and S1. Altogether, excepting S1
and S1, the substrate binding subsites of C1r exhibittion c225 in both C1r and C1s, neither of these proteases
exhibits the Na binding channel seen in several haemo- steric constraints that are likely to contribute to its highly
restricted substrate specificity.static proteases [25, 26], confirming that there is no
absolute relationship between these two features.
Access to the S2 subsite is impeded by the tip of A Highly Flexible Zymogen Structure
Analysis of the structure of the SP domain in the S637Athe flexible insertion loop B, particularly Glu491(c60),
supporting the hypothesis that this loop adapts to sub- proenzyme mutant reveals a number of differences
when compared to the zymogen structures previouslystrates and/or inhibitors, as observed in thrombin [20].
Phe537(c99) also blocks S2 (Figure 3), suggesting that determined for molecules A and B of the R446Q dimer
(Figure 4A). Thus, in contrast with these structures, theeither its side chain moves to allow substrate binding
or the P2 substrate residue is reoriented toward activation site consisting of residues Gln445(c14)-
Arg446(c15) is not stabilized by the crystal packingTyr529(c94), Cys633(c191), and His485(c57), on the
edge of the pocket. Obstruction of the S2 site by and hence is not well defined in the electron density.
Nevertheless, the surrounding 443(c12)-444(c13) andPhe(c99) is a feature common to C1r and C1s [16] and
to blood coagulation factor IX [27]. Access to S3 is 447(c16)-448(c17) segments exhibit ordered structures
that are markedly closer to those seen in molecule B ofexpected to be hindered by the side chains of
Arg612(c173D) at the entrance of the pocket, and of R446Q. These observations indicate a very high flexibil-
ity of the activation site in proenzyme C1r, a feature thatTyr535(c97B) (Figure 3). Asp614(c174B), at the bottom
of the pocket, seems to be properly positioned to bind was already implicit from the observation that this site
shows two strikingly different conformations in mole-either the Arg or Lys residue occupying the P3 position
in C1r and C1s, respectively. The occurrence of aro- cules A and B of the R446Q dimer (Figure 4A) [17].
Conversely, in contrast to the R446Q structures, seg-matic or hydrophobic residues, including Tyr535(c97B),
Phe527(c99), Trp659(c215), and Ile661(c217), at the ment 490(c59C)–500(c64) is stabilized by crystal con-
tacts in the S637A SP domain and hence exhibits aedge of the pocket, seems appropriate for the recogni-
tion of the Val residue at the P3 position in C1 inhibitor different conformation, indicating that this surface loop
B is also very flexible in the zymogen (Figure 4A). Two(Figure 3B).
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Figure 4. Structural Comparison of the C1r
SP Domains
(A) Distance plots between corresponding C
atoms after superimposition of the zymogen
structures seen in S637A and in monomers A
and B of the R446Q dimer. Blue , distances
between the S637A and R446Q(A) structures;
, distances between the S637A and R446Q(B)
structures; red , distances between the
R446Q(A) and R446Q(B) structures. Loop
numbering is indicated at the bottom of the
figure according to Perona and Craik [19].
Crystal contacts are shown on top of the fig-
ure: blue x, contacts due to S637A packing;
purple , contacts due to R446Q(A) packing;
, contacts due to R446Q(B) packing.
(B) Distances between corresponding C
atoms after superimposition of the active WT
structure and the zymogen structures seen
in S637A and in monomers A and B of the
R446Q dimer. , distances between the ac-
tive structure and the zymogen S637A struc-
ture; red , distances between the active
structure and the zymogen R446Q(A) struc-
ture; blue , distances between the active
structure and the zymogen R446Q(B) struc-
ture. Horizontal bars on top of the figure rep-
resent segments that form the activation do-
main as defined by Huber and Bode [28].
other segments of the S637A SP domain, 535(c97B)– the changes leading to the proper active conformation
take place in the activation domain of the protease (as538(c100) (loop C) and 659(c215)–665(c223) (loop 2) also
exhibit different conformations, although with reduced defined by Huber and Bode [28]; Figure 4B), as observed
previously in chymotrypsinogen [29], trypsinogen [28],distance shifts compared to the R446Q structures. Inter-
estingly, the 562(c124)–570(c132) loop on the C-terminal prethrombin-2 [20], and plasminogen [30]. Thus, the
larger distance shifts between the active and zymogenside of the interdomain trans-segment has a conforma-
tion virtually identical to that of molecule A of the R446Q conformations are observed in segments 441(c8)–
444(c11) and 447(c16)–450(c19), on either sides of thedimer but strikingly different from that of molecule B
(Figure 4A). As in the active SP domain, this loop exhibits cleaved Arg446(c15)-Ile447(c16) bond, as well as in the
oxyanion-stabilizing loop 1 (residues 625[c185]–635[c193]),the conformation also observed in S637A and R446Q
(A) (see Figure 4B), and it is likely that the unique confor- in loop 2 (residues 659[c215]–668[c226]), and in loop
D (residues 580[c142]–587[c152]). The most significantmation seen in R446Q (B) is due to crystal packing.
No electron density was found for the 581(c143)– structural change takes place in loop 1, with a shift of
585(c150) segment (loop D) in any of the three proen- about 8 A˚ observed at the level of residue Gln634(c192),
zyme structures. Similarly, loop 3 (residues 604[c169]– a position where the three zymogen structures are very
619[c179]) shows a very high mobility in the three similar. From a functional point of view, this change
molecules and hence could not be fully traced. In con- enables the transition from a distorted to a functional
trast, the conformation of the 624(c184)–636(c194) seg- oxyanion hole: the amide groups of the three highly
ment (loop 1), which comprises the distorted oxyanion conserved Gly(c193), Asp(c194), and Ser(c195), which
hole and exhibits a local 310 helical structure, is remark- together stabilize the negative charge that develops on
ably conserved in the three models (Figure 4A). Alto- the carbonyl oxygen of the transition state. In addition,
gether, comparative analysis of the three zymogen this change contributes to the correct conformation of
structures of the C1r SP domain reveals as many as one flank of the primary specificity pocket. Thus, the
seven segments exhibiting relative distance shifts3 A˚. Asp631(c189) side chain, which is fully exposed at the
surface in the zymogen, reaches its active position at
the bottom of this pocket upon activation. Formation ofC1r Activation Involves Concerted Conformational
the correct specificity pocket also requires the con-Changes in the Activation Domain
certed conformational change of loop 2, at the S1 en-and in Loop 3
trance frame. The C atoms of Cys633(c191) andThe conformational changes between the active and
Cys663(c220) that link loops 1 and 2 by a disulfide bridgezymogen structures are summarized in Figure 4B. Be-
sides the differences found at the flexible surface loops, move about 3 A˚ upon this conformational change. Over-
Monomeric Structures of C1r Catalytic Domain
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all, the observed changes correspond to those occurring structural constraints are important determinants in the
selectivity of C1r for its unique serum protein inhibitor,during activation of other known SPs. However, the am-
plitude of the shifts observed in loops 1 and 2 of C1r is C1 inhibitor. From the crystal structure of the active
C1r SP domain, and the knowledge of the amino acidcomparable to that observed in the coagulation/fibrino-
lysis and complement enzymes but much higher than sequences surrounding its cleavage site in its three sub-
strates (i.e., C1s, C1 inhibitor, and itself), it should bethat observed for the pancreatic enzymes.
Significant shifts are also observed in loop 3 (also possible to design synthetic inhibitors that will selec-
tively block C1 activation at its initial stage.known as the “Met loop,” residues 600[c165]–
618[c178]), which is in the vicinity of loop 2 (Figure 4B). An important conclusion to be drawn from the present
study is that, contrary to what was believed previouslyThese conformational changes are likely to be involved
in the concerted activation rearrangements, as the side based on available three-dimensional structures [16,
17], the interface between the CCP2 module and the SPchain of Ile661(c217) in the active form reaches the posi-
tion occupied by the side chain of Trp606(c171) in the domain in C1r is not completely rigid but exhibits some
flexibility, due to the presence of a restricted hinge atS637A zymogen structure, whereas Tyr667(c225) moves
to the position of Ala602(c167). Changes of reduced the level of Val433. This flexibility is likely to arise largely
from the fact that, whereas the C1s CCP2-SP interface isamplitude (4 A˚) were also observed in loop 3 during
activation of plasminogen [30]. mostly stabilized by 3 tyrosine residues (Tyr375, Tyr376,
and Tyr377) from the CCP2 module, the latter of these
residues (position 395) is replaced by Lys in C1r. Thus,
Conclusions it may be hypothesized that, as indicated by our previous
The availability of three different proenzyme structures crystallographic analysis [16], the CCP2-SP interface is
of the C1r SP domain, obtained using two different crys- completely rigid in C1s. In the case of C1r, the CCP2-
tal forms, provides clear evidence that this zymogen SP interface is probably stabilized in the homodimeric
has a highly flexible structure. This applies in particular R446Q structure, but is likely to be slightly flexible in
to the activation site region of the SP domain and to the monomeric species. This flexibility may be relevant
loop B, both exhibiting a high degree of mobility, as well to the function of C1r in C1, particularly the initial autoac-
as to loops D and 3, which have no matching electron tivation step, which is thought to be mediated by a
density in any of the three structures. In contrast, the transient form generated by disruption of the homodi-
distorted oxyanion hole has a similar structure in all meric structure [17]. Indeed, limited flexibility at the
three cases. CCP2-SP interface may be useful to achieve productive
The resolution of the active structure of the C1r SP positioning of one C1r molecule with respect to its part-
domain allows a detailed analysis of the conformational ner in the confined space of the C1 macromolecule. The
changes that take place during activation, and reveals same may be true for the subsequent C1r-mediated C1s
multiple significant changes. Thus, major changes occur cleavage reaction, which again requires fine positioning
on both sides of the activation site, and in loops 1, of the C1r active site with respect to the C1s activation
2, 3, and D. This is best illustrated by the oxyanion- site.
stabilizing loop, which is the segment where the C1r
zymogen structures are the most similar and where ma-
jor changes take place upon activation, with a maximal Crystal Interactions Reveal Possible Intermediate
States of the C1r Self-Activation Processshift of 8 A˚. Loop E, in contrast, shows the same-helical
structure in all four available SP structures, proenzyme Although it is tempting to precisely model the enzyme-
substrate activating complex based on the structuresor active, monomeric (WT and S637A) or homodimeric
(R446Q). Although this segment plays a central role in now available for the active and proenzyme C1r SP do-
mains, this is made difficult by the fact that recognitionthe assembly of the R446Q dimer [17], it seems clear
that its -helical conformation, which is unique among involves flexible loops of both the enzyme and the sub-
strate. However, information relevant to the C1r self-known SP domain structures, is not acquired upon dimer
formation. It does, however, allow the C1r catalytic do- activation mechanism may be drawn from the relative
positioning of the molecules in the two crystal formsmain to associate as a homodimer. Two further charac-
teristic features of the C1r SP domain that may be in- used in this study. In the previously reported structure
of the dimeric CCP1-CCP2-SP C1r fragment [17], thevolved in its particular catalytic functions are loop B and
loop 3. Loop B, a major insertion of the C1r SP domain, relative positioning of the SP domains was totally unpro-
ductive in terms of activation (see Figure 5C). In contrast,is the only disordered part of the active structure, and
prevents access to the S2 substrate binding subsite. It is the crystal contacts observed in the two monomeric
structures presented here are likely to be representativevery likely, therefore, that this loop undergoes structural
changes upon substrate and/or inhibitor binding, as ob- of different states of the activation process. Thus, the
wild-type active molecules are packed in such a wayserved in thrombin [20]. Loop 3 has a longer -helical
structure in C1r than in other SP domains. Analysis of that they form an “enzyme-product” complex (Figure
5A) likely to be similar to the one occurring upon C1the substrate binding subsites reveals restrained access
to most of them, with the exception of S1 and S1. It is activation. It should be mentioned, though, that there is
a slight shift in the relative positioning of the SP domainsnoteworthy that the C1r catalytic activity is confined to
the interior of the C1 complex and therefore is not nor- (about 6–7 A˚), due to the fact that Arg444 of the “prod-
uct” is found in the active site pocket of the “enzyme”mally exposed to serum protein substrates, as is C1s.
Therefore, it may be hypothesized that the observed instead of the expected Arg446. Overall, the positioning
Structure
1516
Figure 5. Implications of the Major Crystal Interactions on the C1r Self-Activation Process
(A) Major crystal contact observed for the WT active form, illustrating that the Arg444(c13) of one molecule (green) is positioned in the S1
binding pocket of the other molecule (red).
(B) Major crystal contact observed for the S637A mutant.
(C) Bottom view of a macroscopic model of C1 [4, 17].
(D) Refined model of the C1r self-activation mechanism in C1, illustrating three putative states of the activation process (see text). Monomers
A and B are shown in green and red, respectively. Arrows indicate the amplitude and direction of the required displacements.
of the molecules in this configuration is reminiscent of, proenzyme S637A mutant (Figure 5B) reveals a different,
almost symmetrical positioning of the SP domains, withalthough not strictly identical to, that derived from the
enzyme-product assembly observed in the microplas- the active sites facing away from each other at a dis-
tance of 25 A˚, and might represent an intermediate statemin-staphylokinase-microplasmin ternary complex [31].
The assembly observed in the crystal packing of the of the activation process. In this configuration, the ex-
Monomeric Structures of C1r Catalytic Domain
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tended loop B of each SP domain interacts with loops Table 3. Data Collection and Processing Statistics for the
C, 2, and 3 of its counterpart, therefore playing an essen- Proenzyme (S637A) and Active (WT) Forms
tial role in the mutual recognition process. Both the
Proenzyme Active
assemblies observed in the wild-type and S637A crys- native 1 native 2
tals show extensive shape complementarity, with total Unit cell parameters a  b  167.06 A˚ a  112.91 A˚
buried surfaces of 1600 A˚2 and 1580 A˚2, respectively, b  49.46 A˚
c  43.65 A˚ c  77.25 A˚slightly larger than the surface buried at each of the
	  120   106.19two CCP1-SP interfaces in the stable CCP1-CCP2-SP
Space group P64 C2homodimeric structure [16].
Resolution (A˚) 3.2 2.8
The above information may subsequently be used to Number of measures 48,443 25,998
refine our previous model of C1r self-activation in the Redundancy 4.4 (3.6)a 2.6
context of the C1 complex [17] (see Figure 5C). Thus, Completeness (%) 95.9 (95.3)a 98.9 (99.9)a
I/
(I) 5.0 (1.8)a 7as depicted in Figure 5D, state 1, observed in the R446Q
Rsym (%)b 12 (36)a 6.5 (18.9)adimer [17], is likely to represent the resting proenzyme
state. State 2, observed in the S637A crystal form (see a Numbers in parentheses correspond to the highest resolution shell:
3.37–3.2 A˚ for native 1, 2.87–2.8 A˚ for native 2.Figure 5B), would represent the initial contact between
b Rsym  [I  I]/I, where the summation is over all symmetry-the SP domains that follows disruption of the dimeric
equivalent reflections.assembly after target recognition by C1q [17]. State 3,
observed in the WT crystal form (see Figure 5A), is likely
to be close to the final enzyme product state generated
Experimental Proceduresby the C1r activation process. These states appear com-
patible within the context of the C1 complex, assuming
Protein Expression and Purificationflexibility at interdomain junctions, and a displacement
The wild-type (WT) and S637A recombinant fragments spanning the
of the C1q arms upon target recognition [17]. first CCP module and the SP domain of human C1r were expressed
using a baculovirus/insect cell system and purified as described
previously [18]. The proteins each comprise the human C1r segment
Asp358–Glu688, with either the wild-type sequence or a mutationBiological Implications
(Ser637Ala) at the active site serine residue. The sequence is pre-
ceded in both cases by an Asp-Leu sequence added at the N termi-The C1 complex of complement plays a crucial role in
nus due to introduction of a restriction site at the 5 end of theinnate immunity and in various pathologies. This role
cDNA. Briefly, recombinant baculoviruses were generated using the
derives from its ability to bind to pathogens and other Bac-to-Bac system (Life Technologies) and used to infect High
structures from self, and to convert the resulting recog- FiveTM insect cells in serum-free medium. The recombinant proteins
were purified from the cell culture supernatant by anion exchangenition signal into proteolytic activities that in turn initiate
chromatography on a Q-Sepharose Fast Flow column followed byspecific effector reactions. C1r plays a central role in
hydrophobic interaction chromatography on a TSK-Phenyl column.this process, and we still only poorly understand the
mechanisms that underlie its unique ability to mediate
Crystallization and Data Collection
self-activation and then to cleave its partner protease Pooled fractions of the recombinant S637A fragment were concen-
C1s. The crystal structure of a proenzyme, homodimeric trated to 8 mg/ml in 50 mM triethanolamine-hydrochloride, 145 mM
NaCl (pH 7.4). Crystals were obtained at room temperature (20C)fragment from the catalytic domain of human C1r [17]
by the hanging drop vapor diffusion method. The reservoir solutionhas provided the first precise insights into these mecha-
contained 1 ml of 1.5 M ammonium sulfate and 100 mM TAPS (pHnisms. The two structures described in this report shed
8.4). Small needles were flash-cooled at liquid N2 temperature andadditional light on the structural correlates of C1r activa-
a native data set was measured to a resolution of 3.2 A˚ on the ID13
tion and activity. Thus, it is shown that, in addition to the synchrotron beamline at the ESRF, Grenoble (see cell parameters
highly flexible interface likely occurring at the junction in Table 3). The crystal was processed using MOSFLM software
[32]. The data were further scaled and reduced using the CCP4 suitebetween modules CCP1 and CCP2 [17], there is limited
of programs [33]. Details are given in Table 3.flexibility at the interface between CCP2 and the SP
Crystals of the wild-type, active C1r fragment were obtained atdomain. The occurrence of hinges with varying degrees
20C with 12%–20% PEG6000 as a precipitant, 100 mM HEPES (pHof flexibility at various points of the C1r molecule proba-
7.5), and 20% glycerol or 5% PEG400 as additive. Crystals were
bly accounts for its ability to carry out its highly special- flash-cooled at liquid N2 temperature and their diffraction power
ized functions in the constrained context of the C1 com- was tested on the ESRF BM14 beamline. A high-quality native data
set was collected on the ESRF BM30 beamline at 2.8 A˚ resolution,plex. Other key features relevant to C1r function that
with 0.1 mm slit openings, and the beam was centered on the mostare revealed by our study are the high degree of flexibility
ordered region of the crystal in order to minimize mosaic spread.of the zymogen, the multiple conformational changes
Automated data processing [34] was used and the data scalingthat take place upon activation, and the restricted ac-
and reduction were slightly further refined using the CCP4 suite of
cess to the substrate binding subsites. In addition, the programs [33]. Details are given in Table 3.
packing of the molecules in the two crystals used in this
study yields information on the relative positioning of Structure Determination, Refinement, and Analysis
Space group assignments were confirmed by molecular replace-the C1r SP domains that are likely to be relevant to the
ment searches using AMoRe [35], resulting in unambiguous con-C1r self-activation process. A further contribution of this
trasted solutions. The search model was the CCP2-SP fragment ofreport is to open the way to the rational design of syn-
the dimeric CCP1-CCP2-SP C1r structure [17]. The initial models
thetic inhibitors that could be used to specifically block were corrected with the computer graphics program O [36]. Model
complement activation at its early stage under patholog- building was alternated with crystallographic refinement using CNS
[37]. All but the 5% reflections excluded for the Rfree calculationical situations.
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[38] were used in the maximum likelihood-targeted refinement. The 17. Budayova-Spano, M., Lacroix, M., Thielens, N.M., Arlaud, G.J.,
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